Kharouf et al. Secondary biologic failure in PsA common - 36% over 5 years. Predictors - higher baseline SJC HR 1.39 and
Tweet Content
Kharouf et al. Secondary biologic failure in PsA common - 36% over 5 years. Predictors - higher baseline SJC HR 1.39 and PASI HR 1.14. TNFi did better, HR 0.40, esp golimumab - but ?this as often used as first bDMARD? @RheumNow #ACR24 Abstr#1455 https://t.co/ET0WX6tKMr https://t.co/iVcCkM0hu3
Links
Incidence and Predictors of Secondary Failure to Biologic Therapy in Patients w…
https://acrabstracts.org/abstract/incidence-and-predictors-of-secondary-failure…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off